As SGLT2 drugmakers count on the blockbuster diabetes drugs for growth, a team of researchers has tracked dozens of cases of Fournier’s gangrene, a flesh-eating bacterial infection in the genitals, among patients using the drugs.
As SGLT2 drugmakers count on the blockbuster diabetes drugs for growth, a team of researchers has tracked dozens of cases of Fournier’s gangrene, a flesh-eating bacterial infection in the genitals, among patients using the drugs.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
